Lipitor Lawsuit Allegations Backed by Recent Study Findings on High-Potency Statins and Diabetes

Published on September 30, 2013 by Sandy Liebhard

Text-Size:A A A+


A study published earlier this year may add weight to dozens of Lipitor lawsuit filings that assert the popular statin can cause Type 2 diabetes. The research, which appeared in May in the British Medical Journal, found that patients who took high-potency statins like Lipitor may have a higher risk of developing the condition compared to those taking lower-potency drugs, such as Prevachol.

The study, which was conducted by Canadian researchers, looked at a number of statins, including Lipitor, Zocor, Crestor and Prevachol. The higher-potency statins – Lipitor, Crestor and Zocor – were associated with the highest risk of new-onset diabetes among patients with no previous history of the disease, with Lipitor increasing the risk by about 22 percent. The study also found evidence that dosage had no affect on the higher diabetes risk seen with Lipitor and Zocor. However, the risk associated with Crestor was dependent on both dose and duration.

Not only was Prevachol not linked to an increased likelihood of developing Type 2 diabetes, the study indicated that it might actually prevent the disease.

Other Studies See Lipitor Diabetes Risk

This isn’t the first study to indicate a possible danger of Lipitor diabetes among patients who use the statin. In 2012, the U.S. Food & Drug Administration (FDA) mandated that new warnings be added to the Lipitor label because of research that indicated the drug could be associated with the onset of Type 2 diabetes. Just a month prior, a study of post-menopausal women found that those who took Lipitor and other statins faced “a 48 percent increased risk of diabetes.”

Since the FDA alert was issued, numerous Lipitor lawsuits have been filed on behalf of patients who allege their use of the drug resulted in the development of diabetes. Plaintiffs in federally-filed claims did attempt to have these cases consolidated in single federal jurisdiction for pretrial proceedings, but the request was denied this past summer. However, court records indicate that a federal judge in U.S. District Court, District of South Carolina, is informally handling Lipitor diabetes claims in a coordinated manner. Pfizer, which markets Lipitor, is apparently willing to participate in this process.

Discuss a Lipitor Lawsuit with One of Our Attorneys Today

If you or a loved one suffered the onset of Type 2 diabetes after taking Lipitor, you may be eligible to file your own Lipitor lawsuit. To speak with a qualified Lipitor lawyer about your case, please contact Bernstein Liebhard LLP at for a free legal review.